Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -1.49% | -3.98% | -8.30% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34.12M 24.87M |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.12M | Net income 2025 * | -23M -16.76M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.88
x | P/E ratio 2025 * |
-2.41
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
1 day | -1.49% | ||
1 week | -3.98% | ||
Current month | -4.68% | ||
1 month | -7.99% | ||
3 months | -20.90% | ||
6 months | +26.79% | ||
Current year | -8.30% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 2.65 | -1.49% | 12,918 |
24-05-22 | 2.69 | -1.47% | 2,569 |
24-05-21 | 2.73 | +0.92% | 15,779 |
24-05-20 | 2.705 | +0.56% | 13,673 |
24-05-17 | 2.69 | -2.53% | 15,108 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.30% | 24.91M | |
+38.69% | 728B | |
+33.78% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.85% | 244B | |
+7.65% | 207B | |
-5.56% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- ACST Stock